Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
- PMID: 34738022
- PMCID: PMC8561258
- DOI: 10.1093/ofid/ofab434
Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
Abstract
Background: Guidance on the recommended durations of antibiotic therapy, the use of oral antibiotic therapy, and the need for repeat blood cultures remain incomplete for gram-negative bloodstream infections. We convened a panel of infectious diseases specialists to develop a consensus definition of uncomplicated gram-negative bloodstream infections to assist clinicians with management decisions.
Methods: Panelists, who were all blinded to the identity of other members of the panel, used a modified Delphi technique to develop a list of statements describing preferred management approaches for uncomplicated gram-negative bloodstream infections. Panelists provided level of agreement and feedback on consensus statements generated and refined them from the first round of open-ended questions through 3 subsequent rounds.
Results: Thirteen infectious diseases specialists (7 physicians and 6 pharmacists) from across the United States participated in the consensus process. A definition of uncomplicated gram-negative bloodstream infection was developed. Considerations cited by panelists in determining if a bloodstream infection was uncomplicated included host immune status, response to therapy, organism identified, source of the bacteremia, and source control measures. For patients meeting this definition, panelists largely agreed that a duration of therapy of ~7 days, transitioning to oral antibiotic therapy, and forgoing repeat blood cultures, was reasonable.
Conclusions: In the absence of professional guidelines for the management of uncomplicated gram-negative bloodstream infections, the consensus statements developed by a panel of infectious diseases specialists can provide guidance to practitioners for a common clinical scenario.
Keywords: bacteremia; blood cultures; duration of therapy; oral step-down therapy.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
References
-
- Yahav D, Franceschini E, Koppel F, et al. ; Bacteremia Duration Study Group. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis 2019; 69:1091–8. - PubMed
-
- Chotiprasitsakul D, Han JH, Cosgrove SE, et al. ; Antibacterial Resistance Leadership Group. Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort. Clin Infect Dis 2018; 66:172–7. - PMC - PubMed
-
- Nelson AN, Justo JA, Bookstaver PB, et al. . Optimal duration of antimicrobial therapy for uncomplicated gram-negative bloodstream infections. Infection 2017; 45:613–20. - PubMed
-
- von Dach E, Albrich WC, Brunel AS, et al. . Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA 2020; 323:2160–9. - PMC - PubMed
-
- Hojat LS, Bessesen MT, Huang M, et al. . Effectiveness of shorter versus longer durations of therapy for common inpatient infections associated with bacteremia: a multicenter, propensity-weighted cohort study. Clin Infect Dis 2020; 71:3071–8. - PubMed
LinkOut - more resources
Full Text Sources
Medical
